为了推广迷幻疗法,需要什么?
Stephen N Xenakis1, Scott M Shannon2,3
1Uniformed University of Health Sciences, Bethesda, Maryland.
Current opinion in psychiatry
|May 10, 2024
概括
迷幻疗法正在迅速发展,新的法规正在出现. 需要明确的临床指导,但关于这些是否是药理学或心理治疗干预的辩论阻碍了进展.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 迷幻疗法越来越多地被纳入主流医疗保健.
- 监管框架和临床指导方针仍在发展.
- 一个核心的哲学辩论存在关于迷幻干预的主要性质:药物或心理治疗.
研究的目的:
- 审查目前的迷幻疗法的现状.
- 突出临床指导方针和监管的迫切需要.
- 解决影响实践交付的哲学分歧.
主要方法:
- 审查最近的监管变化和临床试验进展.
- 分析美国 (科罗拉多州,俄勒冈州) 和澳大利亚的立法行动.
- 检查有关凯胺的远程处方问题的问题.
主要成果:
- 治疗PTSD的MDMA辅助疗法正在FDA审查中,可能在2024年获得批准.
- 澳大利亚已将psilocybin和MDMA合法化,用于受监管的使用.
- 美国有几个州正在合法化或考虑将迷幻药合法化,但人们仍然担心家庭内使用胺类药物.
结论:
- 迷幻治疗正在迅速进入主流医疗保健.
- 迫切需要一致的临床指导方针和监管.
- 解决药理与心理治疗的辩论对于有效的指导和融入医疗保健至关重要.
相关概念视频
01:22CNS Stimulants: Psychedelic Agents
147
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
147
01:27Hallucinogens and Psychedelics
164
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
164
01:30Psychosurgery
53
Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
53
01:28Drug Therapy
42
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
42
01:24Treatment Strategies for Psychological Disorders
115
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
115
01:11Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K